Immunomodulatory effects of Lactobacillus and Bifidobacterium on both murine and human mitogen-activated T cells

International Archives of Allergy and Immunology

Volumn 156, Issue 2, 2011, Pages 128-136

  Li, Chia Yang ^a   Lin, Hung Chih ^b,c   Lai, Chih Ho ^d   Lu, John Jenn Yenn ^e   Wu, Shu Fen ^b   Fang, Shih Hua ^f  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b China Medical University Hospital   (China)

^c School of Chinese Medicine   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e National Taichung Nursing College   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY OF SPORT   (Taiwan)

Author keywords

Bifidobacterium; Lactobacillus; Probiotics; T cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MITOGENIC AGENT; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LACTOBACILLUS; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; BIFIDOBACTERIUM; CELL CYCLE; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-4; LACTOBACILLUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROBIOTICS; T-LYMPHOCYTES;

EID: 79955889020     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000322350     Document Type: Article

References (44)

1. Dotan I, Rachmilewitz D: Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr Opin Gastroenterol 2005;21:426-430. (Pubitemid 40961168)
2. Reiff C, Kelly D: Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol 2010;300:25-33.
3. Gronlund MM, Lehtonen OP, Eerola E, Kero P: Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999;28:19-25. (Pubitemid 29292870)
4. Drakes M, Blanchard T, Czinn S: Bacterial probiotic modulation of dendritic cells. Infect Immun 2004;72:3299-3309. (Pubitemid 38697752)
5. Zeuthen LH, Christensen HR, Frokiaer H: Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with Gram-negative bacteria. Clin Vaccine Immunol 2006;13:365-375.
6. Kanzato H, Fujiwara S, Ise W, Kaminogawa S, Sato R, Hachimura S: Lactobacillus acidophilus strain l-92 induces apoptosis of antigenstimulated T cells by modulating dendritic cell function. Immunobiology 2008;213:399-408. (Pubitemid 351619283)
7. Fanaro S, Chierici R, Guerrini P, Vigi V: Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003;91:48-55. (Pubitemid 37239252)
8. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Dore J, Blaut M: Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006;72:1027-1033. (Pubitemid 43271206)
9. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S: Probiotics: effects on immunity. Am J Clin Nutr 2001;73:444S-450S. (Pubitemid 32113269)
10. Ouwehand AC, Bergsma N, Parhiala R, Lahtinen S, Gueimonde M, Finne-Soveri H, Strandberg T, Pitkala K, Salminen S: Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol 2008;53:18-25. (Pubitemid 351659703)
11. Okada Y, Tsuzuki Y, Hokari R, Komoto S, Kurihara C, Kawaguchi A, Nagao S, Miura S: Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-i kappaB and SOCS gene expression. Int J Exp Pathol 2009;90:131-140.
12. Nakanishi Y, Hosono A, Hiramatsu Y, Kimura T, Nakamura R, Kaminogawa S: Characteristic immune response in Peyer's patch cells induced by oral administration of Bifidobacterium components. Cytotechnology 2005;47:69-77. (Pubitemid 41784667)
13. Lopez P, Gueimonde M, Margolles A, Suarez A: Distinct bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol 2010;138:157-165.
14. Kato I, Tanaka K, Yokokura T: Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int J Immunopharmacol 1999;21:121-131. (Pubitemid 29112837)
15. Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F, Malagelada JR: Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002;51:659-664. (Pubitemid 35216852)
16. Van Deventer SJ: Tumour necrosis factor and Crohn's disease. Gut 1997;40:443-448. (Pubitemid 27204920)
17. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205. (Pubitemid 28307304)
18. Targan SR: Biology of inflammation in Crohn's disease: mechanisms of action of anti-TNF-a therapy. Can J Gastroenterol 2000;14 Suppl C:13C-16C.
19. Fang SH, Hwang LH, Chen DS, Chiang BL: Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J Hepatol 2000;33:791-798.
20. Hovi T, Suni J, Hortling L, Vaheri A: Stimulation of chicken lymphocytes by T-and Bcell mitogens. Cell Immunol 1978;39:70-78. (Pubitemid 9022454)
21. Toivanen P, Toivanen A: Selective activation of chicken T lymphocytes by concanavalin A. J Immunol 1973;111:1602-1603.
22. Abbas AK, Lichtman AH, Pober JS: Cellular and Molecular Immunology, ed 2. Philadelphia, W. B. Saunders, 1994.
23. Rao YK, Fang SH, Tzeng YM: Inhibitory effects of the flavonoids isolated from Waltheria indica on the production of NO, TNF-alpha and IL-12 in activated macrophages. Biol Pharm Bull 2005;28:912-915. (Pubitemid 40740667)
24. Perdigon G, Maldonado Galdeano C, Valdez JC, Medici M: Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002;56(suppl 4):S21-S26. (Pubitemid 36163799)
25. Oelschlaeger TA: Mechanisms of probiotic actions - a review. Int J Med Microbiol 2010;300:57-62.
26. Matsuzaki T, Chin J: Modulating immune responses with probiotic bacteria. Immunol Cell Biol 2000;78:67-73. (Pubitemid 30090991)
27. Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E: Lactobacillus GG effect in increasing IFNgamma production in infants with cow's milk allergy. J Allergy Clin Immunol 2004;114:131-136. (Pubitemid 39005129)
28. Gill HS, Rutherfurd KJ, Prasad J, Gopal PK: Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (hn001), Lactobacillus acidophilus (hn017) and Bifidobacterium lactis (hn019). Br J Nutr 2000;83:167-176. (Pubitemid 30093049)
29. Rafter JJ: The role of lactic acid bacteria in colon cancer prevention. Scand J Gastroenterol 1995;30:497-502.
30. Sasaki T, Fukami S, Namioka S: Enhanced resistance of mice to Escherichia coli infection induced by administration of peptidoglycan derived from Bifidobacterium thermophilum. J Vet Med Sci 1994;56:433-437.
31. Sasaki T, Fukami S, Namioka S: Enhancement of cytotoxic activity of lymphocytes in mice by oral administration of peptidoglycan (PG) derived from Bifidobacterium thermophilum. J Vet Med Sci 1994;56:1129-1133.
32. Sekine K, Ohta J, Onishi M, Tatsuki T, Shimokawa Y, Toida T, Kawashima T, Hashimoto Y: Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol Pharm Bull 1995;18:148-153.
33. Nosova T, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M: Acetaldehyde production and metabolism by human indigenous and probiotic Lactobacillus and Bifidobacterium strains. Alcohol Alcohol 2000;35:561-568.
34. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, Oh W: Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4. (Pubitemid 43046273)
35. Reid G, Howard J, Gan BS: Can bacterial interference prevent infection? Trends Microbiol 2001;9:424-428. (Pubitemid 32844328)
36. Coconnier MH, Bernet MF, Chauviere G, Servin AL: Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J Diarrhoeal Dis Res 1993;11:235-242.
37. Coconnier MH, Bernet MF, Kerneis S, Chauviere G, Fourniat J, Servin AL: Inhibition of adhesion of enteroinvasive pathogens to human intestinal caco-2 cells by Lactobacillus acidophilus strain lb decreases bacterial invasion. FEMS Microbiol Lett 1993;110:299-305. (Pubitemid 23212968)
38. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A: Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-497.
39. Schiffrin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A: Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997;66:515S-520S. (Pubitemid 27360357)
40. Kailasapathy K, Chin J: Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000;78:80-88. (Pubitemid 30090993)
41. Bloksma N, de Heer E, van Dijk H, Willers JM: Adjuvanticity of lactobacilli. 1. Differential effects of viable and killed bacteria. Clin Exp Immunol 1979;37:367-375. (Pubitemid 9214624)
42. Popova P, Guencheva G, Davidkova G, Bogdanov A, Pacelli E, Opalchenova G, Kutzarova T, Koychev C: Stimulating effect of DEODAN (an oral preparation from Lactobacillus bulgaricus 'lb51') on monocytes/macrophages and host resistance to experimental infections. Int J Immunopharmacol 1993;15:25-37. (Pubitemid 23025107)
43. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH: Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344:1046-1049. (Pubitemid 24310035)
44. Miettinen M, Vuopio-Varkila J, Varkila K: Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996;64:5403-5405. (Pubitemid 26404010)